UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2010
ALIMERA SCIENCES, INC.
(Exact name of Registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
|
|
001-34703
(Commission File No.)
|
|
20-0028718
(IRS Employer Identification No.) |
6120 Windward Parkway
Suite 290
Alpharetta, Georgia 30005
(Address of principal executive offices and zip code)
Registrants telephone number, including area code: ( 678) 990-5740
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
Item 2.02. |
|
Results of Operations and Financial Condition. |
On
November 4, 2010, Alimera Sciences, Inc. (the
Company) issued a press release and held a conference call regarding its results of operations and financial condition for the third
quarter ended September 30, 2010. The full text of the press release is furnished as Exhibit 99.1
to this Current Report on Form 8-K.
Various statements made during the conference call are forward-looking statements,
within the meaning of the Private Securities Litigation Reform Act of 1995, regarding, among other
things, the Companys future results of operations and financial position, business strategy and
plans and objectives of management for the Companys future operations. Words such as anticipate,
believe, estimate, expect, intend, may, plan, predict, project, likely, will,
would, could, and similar expressions are intended to identify forward-looking statements,
although not all forward-looking statements contain these identifying words. The events and
circumstances reflected in the Companys forward-looking statements may not occur and actual
results could differ materially from those projected in the Companys forward-looking statements.
Meaningful factors which could cause actual results to differ include, but are not limited to,
delay in or failure to obtain regulatory approval of the Companys product candidates, uncertainty
as to the Companys ability to commercialize, and market acceptance of, the Companys product
candidates, the extent of government regulations, uncertainty as to the relationship between the
benefits of the Companys product candidates and the risks of their side-effect profiles,
dependence on third-party manufacturers to manufacture the Companys product candidates in
sufficient quantities and quality, uncertainty of clinical trial results, limited sales and
marketing infrastructure, and the Companys ability to operate its business in compliance with the
covenants and restrictions that it is subject to under its credit facility, as well as other
factors discussed in the Risk Factors and Managements Discussion and Analysis of Financial
Condition and Results of Operations sections of the Companys quarterly reports on Form 10-Q for
the fiscal quarters ended March 31, 2010 and June 30, 2010, which are on file with the Securities
and Exchange Commission (SEC). Additional factors may also be set forth in those sections of the
Companys quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2010 to be filed
with the SEC.
All forward-looking statements made during the conference call are expressly qualified by the
above paragraph in their entirety. These forward-looking statements speak only as of the date of
the conference call (unless another date is indicated). The Company undertakes no obligation, and
specifically declines any obligation, to publicly update or revise any forward-looking statements
which are made during the conference call, whether as a result of new information, future events or
otherwise.
The information in Item 2.02 of this Current Report on Form 8-K and the press release attached
hereto as Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.